Ultrarapid and ultrasensitive detection of SARS‐CoV‐2 antibodies in COVID‐19 patients via a 3D‐printed nanomaterial‐based biosensing platform
Sign Up to like & getrecommendations! Published in 2022 at "Journal of Medical Virology"
DOI: 10.1002/jmv.28075
Abstract: Rapid detection of antibodies during infection and after vaccination is critical for the control of infectious outbreaks, understanding immune response, and evaluating vaccine efficacy. In this manuscript, we evaluate a simple ultrarapid test for SARS‐CoV‐2… read more here.
Keywords: platform; covid patients; antibodies covid; cov antibodies ... See more keywords
Neutralizing monoclonal antibodies for COVID-19 treatment and prevention
Sign Up to like & getrecommendations! Published in 2020 at "Biomedical Journal"
DOI: 10.1016/j.bj.2020.11.011
Abstract: The SARS-CoV-2 pandemic has caused unprecedented global health and economic crises. Several vaccine approaches and repurposed drugs are currently under evaluation for safety and efficacy. However, none of them have been approved for COVID-19 yet.… read more here.
Keywords: nmabs targeting; monoclonal antibodies; treatment; neutralizing monoclonal ... See more keywords
Therapeutic monoclonal antibodies for COVID-19 management: an update
Sign Up to like & getrecommendations! Published in 2022 at "Expert Opinion on Biological Therapy"
DOI: 10.1080/14712598.2022.2078160
Abstract: ABSTRACT Background The severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) has affected more than 529 million people, and today the world is facing different mutant strains of the virus, leading to increased morbidity rates, fatality… read more here.
Keywords: covid management; antibodies covid; therapeutic monoclonal; therapy ... See more keywords
SARS-CoV-2 Neutralizing Antibodies for COVID-19 Prevention and Treatment.
Sign Up to like & getrecommendations! Published in 2021 at "Annual review of medicine"
DOI: 10.1146/annurev-med-042420-113838
Abstract: Prophylactic and therapeutic drugs are urgently needed to combat coronavirus disease 2019 (COVID-19) caused by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2). Over the past year, SARS-CoV-2 neutralizing antibodies have been developed for preventive or… read more here.
Keywords: medicine; covid prevention; neutralizing antibodies; cov neutralizing ... See more keywords
Clinical implications of anti-idiotype antibodies in COVID-19
Sign Up to like & getrecommendations! Published in 2022 at "Journal of Basic and Clinical Physiology and Pharmacology"
DOI: 10.1515/jbcpp-2022-0123
Abstract: Abstract Idiotype-based therapeutics have failed to deliver their promise, necessitating rethinking of the concept and its potential to develop a viable immunotherapy method. The idiotype based hypothesis is discussed in this paper in order to… read more here.
Keywords: idiotype antibodies; antibodies covid; clinical implications; idiotype ... See more keywords